Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch

Transplant Immunology

Volumn 19, Issue 1, 2008, Pages 25-29

  Vigil, Silvana Virginia Gagliotti ^a   de Liz, Rafael ^a   Medeiros, Yara Santos ^a   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anti inflammatory activity; Cytokines; Enzymes; Exudation; Leukocytes; Tacrolimus

Indexed keywords

ADENOSINE DEAMINASE; CARRAGEENAN; CHEMOKINE; CYTOKINE; DEXAMETHASONE; ENZYME; INDOMETACIN; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRATE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; INFLAMMATION; LEUKOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PASSION FRUIT; PLEURISY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADENOSINE DEAMINASE; ANIMALS; CARRAGEENAN; DEXAMETHASONE; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; INDOMETHACIN; INFLAMMATION; INTERLEUKIN-1; MICE; PEROXIDASE; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40849104748     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.01.003     Document Type: Article

References (30)

1. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 40 9 (1987) 1249-1255
2. Bush E.L., and Lin S.S. Lung transplantation: advances in immunosuppression. Thorac Surg Clin 16 4 (2006) 421-433
3. McCormack P.L., and Keating G.M. Tacrolimus: in heart transplant recipients. Drugs 66 17 (2006) 2269-2279
4. Wente M.N., Sauer P., Mehrabi A., Weitz J., Buchler M.W., Schmidt J., and Schemmer P. Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation. Clin Transplant 20 17 (2006) 80-84
5. Nakagawa H. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. Clin Drug Investig 26 5 (2006) 235-246
6. Ezquerra G.M., Regana M.S., Acosta E.H., and Millet P.U. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol 5 4 (2006) 334-336
7. Gonzalez-Lama Y., Gisbert J.P., and Mate J. The role of tacrolimus in inflammatory bowel disease: a systematic review. Dig Dis Sci 51 10 (2006) 1833-1840
8. Yocum D.E., Furst D.E., Kaine J.L., Baldassare A.R., Stevenson J.T., Borton M.A., et al. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum 48 12 (2003) 3328-3337
9. Kitahara K., and Kawai S. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol 19 3 (2007) 238-245
10. Roehrl M.H., Kang S., Aramburu J., Wagner G., Rao A., and Hogan P. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc Natl Acad Sci USA 101 20 (2004) 7554-7559
11. Miyata S., Ohkubo Y., and Mutoh S. A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis. Inflamm Res 54 1 (2005) 1-9
12. Haddad E.M., McAlister V.C., Renouf E., Malthaner R., Kjaer M.S., and Gluud L.L. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 18 4 (2006) 5161
13. Pereira R., Medeiros Y.S., and Fröde T.S. Antiinflammatory effects of tacrolimus in a mouse model of pleurisy. Transpl Immunol 16 2 (2006) 105-111
14. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 2 (1983) 109-110
15. Benincá J.P., Montanher A.B., Zucolotto S.M., Schenkel E.P., and Fröde T.S. Anti-inflammatory effects of the Passiflora edulis: forma flavicarpa Degener inhibition of leukocytes, enzymes and pro-inflammatory cytokine levels in the air pouch model, in mice. Food Chem 104 3 (2007) 1097-1105
16. 15N] nitrate in biological fluids. Anal Biochem 126 1 (1982) 131-138
17. Saleh T.S.F., Calixto J.B., and Medeiros Y.S. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20 8 (1999) 949-956
18. Rao T.S., Currie J.L., Shaffer A.F., and Isakson P.C. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17 6 (1993) 723-741
19. Giusti G., and Galanti B. Adenosine deaminase: colourimetric method. In: Bergmeyer H.U. (Ed). Methods of enzymatic analyses (1984), Verlag Chemie, Weinheim 315-323
20. Rolla G., Ferrero N., Bergia R., and Guida G. Perspectives in clinical immunology. Recent Prog Med 97 12 (2006) 787-796
21. Aiko S., Conner E.M., Fuseler J.A., and Grisham M.B. Effects of cyclosporine or FK506 in chronic colitis. J Pharmacol Exp Ther 280 2 (1997) 1075-1084
22. Lapa e Silva J.R., Ruffié C., Lefort J., Nahori M.A., Vargaftig B.B., and Pretolani M. Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus. Mediat Inflamm 8 1 (1999) 17-23
23. Morishita Y., Hirayama Y., Miyayasu K., Tabata K., Kawamura A., Ohkubo Y., et al. FK506 aerosol locally inhibits antigen-induced airway inflammation in guinea pigs. Int Arch Allergy Immunol 136 4 (2005) 372-378
24. Woolley S.M., Farivar A.S., Naidu B.V., Rosengart M., Thomas R., Fraga C., et al. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg 127 2 (2004) 376-384
25. Sedgwick A.D., and Lees P. A comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat. Agents Actions 18 3-4 (1986) 439-446
26. Magari K., Miyata S., Ohkubo Y., Mutoh S., and Goto T. Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis. Br J Pharmacol 139 5 (2003) 927-934
27. Bressan E., Cunha F.Q., and Tonussi C.R. Contribution of TNF-alpha, IL-1beta and CINC-1 for articular incapacitation, oedema and cell migration in a model of LPS-induced reactive arthritis. Cytokine 36 1-2 (2006) 83-89
28. Magari K., Miyata S., Ohkubo Y., and Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Inflamm Res 53 9 (2004) 469-474
29. Tateda K., Moore T.A., Newstead M.W., Tsai W.C., Zeng X., Deng J.C., et al. Chemokine-dependent neutrophil recruitment in a murine model of legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun 69 4 (2001) 2017-2024
30. Strestikova P., Otova B., Filipec M., Masek K., and Farghali H. Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A. Immunopharmacol Immunotoxicol 23 1 (2001) 67-74